Topic Highlight
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2013; 19(16): 2449-2455
Published online Apr 28, 2013. doi: 10.3748/wjg.v19.i16.2449
Table 1 Studies examining the role of interleukin-6 polymorphism (-174 G/C) in hepatitis C virus and hepatitis B virus infection
Ref.CountryEthnicityCasesControlsGenotyping methodAssociation with chronic hepatitis/response to therapy
Barrett et al[20]IrelandCaucasian158-PCR-SSPPositive significant/-
Nattermann et al[23]GermanyCaucasian210100Cytokine genotyping tray-/Uncertain
Falleti et al[25]ItalyCaucasian121-PCR-RFLPPositive significant /-
Park et al[26]South KoreaAsian1046-PCR-SBENS/-
Ribeiro et al[27]BrazilAmerican12641PCR-SSPNS/-
Table 2 Studies examining the role of interleukin-6 polymorphism (-174 G/C) in alcoholic and autoimmune liver diseases
Ref.CountryEthnicityCasesControlsGenotyping methodAssociation
Carulli et al[33]ItalyCaucasian79114PCR-RFLPPositive significant (NAFLD)
Fernández-Real et al[34]SpainCaucasian32-PCR-RFLPPositive significant (diabetes and lipid abnormalities) (G allele)
Marcos et al[48]SpainCaucasian258101TaqMan genotypingNS (alcoholic liver disease)
Fan et al[53]ChinaAsian77-PCR-RFLPPositive significant (PBC)
Table 3 Studies examining the role of interleukin-6 polymorphism (-174 G/C) in hepatocellular carcinoma
Ref.CountryEthnicityCasesControlsGenotyping methodAssociation with HCC
Nieters et al[65]ChinaAsian250250PCR-RFLPNS
Ognjanovic et al[66]United StatesAmerican11202305’nuclease Taqman allelic discrimination assayPositive significant
Falleti et al[67]ItalyCaucasian219-PCR-RFLPPositive significant
Giannitrapani et al[15]ItalyCaucasian105-PCR-RFLPPositive significant